乳腺癌分期与分级对育龄女性生育力保存结局的影响
回顾性队列研究纳入155例18-38岁接受生育力保存的乳腺癌患者,比较低级别与高级别肿瘤的刺激周期结局。高级别组成熟卵母细胞数(7枚 vs 13枚,P=0.0002)和冷冻胚胎数(3枚 vs 5枚,P=0.02)显著低于低级别组,而高分期与低分期组成熟卵母细胞数无显著差异(8枚 vs 9枚,P=0.06)。
要点
- 高级别乳腺癌患者获成熟卵母细胞数显著少于低级别患者。
- 高级别组冷冻胚胎数也显著低于低级别组。
- 肿瘤分期高低对成熟卵母细胞数无显著影响。
核心结论
- 高级别乳腺癌对成熟卵母细胞总数和冷冻胚胎数有负面影响。
研究设计与样本
- 回顾性队列研究,纳入155例18-38岁接受生育力保存的乳腺癌女性,均使用促性腺激素释放激素拮抗剂方案,排除复发、既往肿瘤治疗、既往卵巢手术及已知卵巢病变者。
主要发现
- 高级别组(n=80,年龄32岁[28-35])成熟卵母细胞数为7枚[4-10],显著低于低级别组(n=75,年龄32岁[28-35])的13枚[7-17],P=0.0002。
- 高级别组冷冻胚胎数为3枚[2-5],显著低于低级别组的5枚[3-9],P=0.02。
- 高分期组(n=73,年龄32岁[28-35])成熟卵母细胞数为8枚[4-13],与低分期组(n=82,年龄33岁[28-35])的9枚[7-15]相比无显著差异,P=0.06。
临床怎么用
- 对高级别乳腺癌患者进行生育力保存咨询时,应告知其获卵数和冷冻胚胎数可能较低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does breast cancer spread and aggressiveness affect fertility-preservation results? DESIGN: Retrospective cohort study of women with breast cancer undergoing fertility-preservation treatment. INCLUSION CRITERIA: age 18-38 years and use of gonadotrophin releasing hormone antagonist protocol; exclusion criteria: recurrent cancer, previous oncological treatment, previous ovarian surgery and known ovarian pathology. Stimulation cycle outcomes of women with low-stage breast cancer were compared with those with high-stage disease. Patients with low-grade (G1-2) were compared with those with high-grade (G3) malignancies. PRIMARY OUTCOME: total number of mature oocytes; secondary outcomes: oestradiol level and number of follicles wider than 14 mm on the day of trigger, number of retrieved oocytes and cryopreserved embryos. RESULTS: The final analysis included 155 patients. Patients with high-grade tumours (n = 80; age 32 years [28-35]) had significantly lower number of mature oocytes compared with patients with low-grade cancer (n = 75; age 32 years [28-35]; seven mature oocytes [4-10] versus 13 mature oocytes [7-17]; P = 0.0002). The number of cryopreserved embryos was also lower in the high-grade group (three [2-5] versus five [3-9]; P = 0.02). Stage-based analysis revealed a similar number of mature oocytes in high-stage (n = 73; age 32 years [28-35]) compared with low-stage group (n = 82; age 33 years [28-35]; eight mature oocytes [4-13] versus nine mature oocytes [7-15]; P = 0.06). CONCLUSIONS: High-grade breast cancer has a negative effect on total number of mature oocytes and cryopreserved embryos.
引用
- Volodarsky-Perel A, Cai E, Tulandi T, et al. Influence of stage and grade of breast cancer on fertility preservation outcome in reproductive-aged women. Reprod Biomed Online. 2019. PMID: 31953011. doi:10.1016/j.rbmo.2019.11.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。